Pharma rates and value Retailers: Sudip Bandyopadhyay Downies Market Outlook

The pharmaceutical sector of India may not be in the headlines, but tariff -related uncertainties remain an important care for investors, says MarktExpert Sudip Bandyopadhyay. “Rate is the greatest uncertainty. Apart from Sun Pharma, most companies are not affected by the current American tariff regime. Even Sun will even avoid the bullet with recent developments. […]

Bet on 3 sectors that generate value in this volatility, be wary in 2 sectors: Nilesh Shetty

Nilesh ShettyPortfolio manager, Quantum advisers, Says Tarief Sonness causes opportunities for long -term investments. Logistics and pharmaceutical sectors become attractive. Banks in the private sector, assets management, insurance and brokers remain important allocations. IT services and consumer -discretionary shares offer reasonable ratings for the coming years. Investors keep a close eye on these sectors for […]